NovaBay Pharmaceuticals Inc (NBY)
0.75
+0.03
(+4.75%)
USD |
NYAM |
Nov 01, 16:00
0.74
-0.01
(-1.33%)
After-Hours: 20:00
NovaBay Pharmaceuticals Total Assets (Quarterly): 3.925M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 3.925M |
March 31, 2024 | 5.357M |
December 31, 2023 | 9.034M |
September 30, 2023 | 12.85M |
June 30, 2023 | 16.01M |
March 31, 2023 | 14.82M |
December 31, 2022 | 16.40M |
September 30, 2022 | 22.38M |
June 30, 2022 | 21.54M |
March 31, 2022 | 24.79M |
December 31, 2021 | 23.98M |
September 30, 2021 | 12.24M |
June 30, 2021 | 13.60M |
March 31, 2021 | 14.07M |
December 31, 2020 | 15.24M |
September 30, 2020 | 17.08M |
June 30, 2020 | 13.27M |
March 31, 2020 | 9.475M |
December 31, 2019 | 11.22M |
September 30, 2019 | 14.60M |
June 30, 2019 | 9.87M |
March 31, 2019 | 9.72M |
December 31, 2018 | 9.361M |
September 30, 2018 | 10.36M |
June 30, 2018 | 11.70M |
Date | Value |
---|---|
March 31, 2018 | 13.82M |
December 31, 2017 | 10.08M |
September 30, 2017 | 11.06M |
June 30, 2017 | 12.07M |
March 31, 2017 | 12.68M |
December 31, 2016 | 15.38M |
September 30, 2016 | 15.14M |
June 30, 2016 | 7.005M |
March 31, 2016 | 4.931M |
December 31, 2015 | 5.077M |
September 30, 2015 | 6.69M |
June 30, 2015 | 10.17M |
March 31, 2015 | 8.155M |
December 31, 2014 | 7.537M |
September 30, 2014 | 11.04M |
June 30, 2014 | 13.51M |
March 31, 2014 | 17.18M |
December 31, 2013 | 15.65M |
September 30, 2013 | 12.24M |
June 30, 2013 | 12.83M |
March 31, 2013 | 15.42M |
December 31, 2012 | 19.24M |
September 30, 2012 | 13.67M |
June 30, 2012 | 12.07M |
March 31, 2012 | 14.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.925M
Minimum
Jun 2024
24.79M
Maximum
Mar 2022
14.59M
Average
14.07M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
Palatin Technologies Inc | 10.74M |
iBio Inc | 28.73M |
Theriva Biologics Inc | 42.39M |
Oragenics Inc | 2.710M |
Nanoviricides Inc | 12.82M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.542M |
Shareholders Equity (Quarterly) | -0.617M |
Debt to Equity Ratio | -1.128 |
Current Ratio | 0.6241 |
Net Debt Paydown Yield | -4.67% |